Profil
Karen M.
King worked as Vice President-Investor Relations at Perdoceo Education Corp.
from 2005 to 2008.
She then held the same position at Hospira, Inc. from 2014 to 2015.
From 2016 to 2018, she served as VP-Investor Relations & Corporate Communications at LivaNova Plc.
Finally, from 2018 to 2022, she was the SVP-Global Investor Relations & Communications at Alcon AG.
Ms. King obtained her undergraduate degree from Indiana University.
Anciens postes connus de Karen M. King
| Sociétés | Poste | Fin |
|---|---|---|
| ALCON INC. | Investor Relations Contact | 01/01/2022 |
| LIVANOVA PLC | Investor Relations Contact | 01/07/2018 |
| HOSPIRA, INC. | Investor Relations Contact | 01/01/2015 |
| PERDOCEO EDUCATION CORPORATION | Public Communications Contact | 01/01/2008 |
Formation de Karen M. King
| Indiana University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| PERDOCEO EDUCATION CORPORATION | Consumer Services |
| ALCON INC. | Health Technology |
| LIVANOVA PLC | Health Technology |
| Entreprise privées | 1 |
|---|---|
Hospira, Inc.
 Hospira, Inc. Pharmaceuticals: MajorHealth Technology Hospira, Inc. provides injectable drugs and infusion technologies. It offers drugs, IV sets and clinical integration, infusion pumps, clinical software and implementation services. The company was founded on September 16, 2003 and is headquartered in Lake Forest, IL. | Health Technology |
